Haleon Plc Ebit Over Time
| HLN Stock | USD 9.72 0.13 1.36% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Haleon Plc Performance and Haleon Plc Correlation. Haleon |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Haleon Plc. If investors know Haleon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Haleon Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.348 | Dividend Share 0.062 | Earnings Share 0.33 | Revenue Per Share 2.446 | Quarterly Revenue Growth (0.01) |
The market value of Haleon plc is measured differently than its book value, which is the value of Haleon that is recorded on the company's balance sheet. Investors also form their own opinion of Haleon Plc's value that differs from its market value or its book value, called intrinsic value, which is Haleon Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Haleon Plc's market value can be influenced by many factors that don't directly affect Haleon Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Haleon Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Haleon Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Haleon Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Ebit Analysis
Compare Haleon plc and related stocks such as Teva Pharma Industries, Bausch Health Companies, and Zoetis Inc Ebit Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TEVA | 7.2 M | 2.9 B | 4.1 B | 2.3 B | 3 B | 3.8 B | 4.7 B | 5.2 B | 3.2 B | 3.2 B | (3.7 B) | 3.1 B | (2.2 B) | 433 M | 411.4 M |
| BHC | (5.9 M) | 430.6 M | 933.2 M | 1.2 B | 2.6 B | 2.7 B | 2.8 B | 549 M | 530 M | (73 M) | 631.7 M | 398.5 M | 1.3 B | 978.4 M | 661.1 M |
| ZTS | 221 M | 653 M | 862 M | 829 M | 962 M | 989 M | 1.4 B | 1.7 B | 2 B | 2.1 B | 2.2 B | 2.7 B | 2.9 B | 3.2 B | 1.7 B |
| TAK | 218.7 B | 271.6 B | 150.1 B | 189.6 B | (112.6 B) | 152.5 B | 166.6 B | 249.1 B | 103.9 B | 100.4 B | 424 B | 600.1 B | 492.1 B | 172.3 B | 253.2 B |
| RDY | 1.4 B | 15.1 B | 16.9 B | 26 B | 26.3 B | 29.6 B | 13.5 B | 11.9 B | 23.6 B | 49.5 B | 32.9 B | 35.9 B | 61.8 B | 73.6 B | 77.3 B |
| EBS | (364 K) | 32.2 M | 41.7 M | 43.4 M | 61.3 M | 96.3 M | 68.6 M | 82.7 M | 91.4 M | 114.1 M | 434.6 M | 331.9 M | (166 M) | (634.4 M) | (602.7 M) |
| HCM | (5.9 M) | 5.6 M | (10.8 M) | 618 K | (7.1 M) | (9.1 M) | (45.7 M) | (52.1 M) | (85.6 M) | (145 M) | (188.9 M) | (215.1 M) | (409.8 M) | 17.3 M | 18.2 M |
| VTRS | 34 M | 1.1 B | 563 M | 1 B | 789 M | 125.3 M | (274 M) | (381.3 M) | (1.3 B) | (1.4 B) | (227.9 M) | (28.2 M) | 3.4 B | 777.8 M | 816.7 M |
| NBIX | (500 K) | 29.7 M | (2.8 M) | (53.9 M) | (69.1 M) | (100.5 M) | (155.1 M) | (133.8 M) | 36.9 M | 219.1 M | 327.5 M | 207.8 M | 249 M | 336.7 M | 353.5 M |
| ELAN | 268.7 M | 268.7 M | 268.7 M | 268.7 M | 268.7 M | 268.7 M | 286 M | 517.5 M | 442.6 M | 342.6 M | (593.7 M) | (307 M) | 184 M | (918 M) | (872.1 M) |
| CTLT | 176.2 M | 223.1 M | 202.9 M | 110.5 M | 94.8 M | 104.5 M | 97 M | 92.2 M | 61.8 M | 143.8 M | 825 M | 726.8 M | (156 M) | (773 M) | (734.4 M) |
| LNTH | (16.7 M) | (16.7 M) | (309 K) | (12 M) | 39.4 M | 22.8 M | 32.2 M | 41.3 M | 53 M | 32.1 M | (2 M) | (67.3 M) | 33.9 M | 431 M | 452.5 M |
| SIGA | (1.4 M) | (40.3 M) | (22.5 M) | (23 M) | (21.2 M) | (16.5 M) | (21 M) | (17.6 M) | 434 M | 500.1 K | 84.5 M | 89.1 M | 42.7 M | 83.6 M | 87.8 M |
| ESPR | (11 M) | (10.2 M) | (10.3 M) | (22.6 M) | (36.3 M) | (49.5 M) | (74.9 M) | (167 M) | (204.6 M) | (93.1 M) | (120.9 M) | (222.8 M) | (176.8 M) | (150.3 M) | (142.8 M) |
Haleon plc and related stocks such as Teva Pharma Industries, Bausch Health Companies, and Zoetis Inc Ebit description
My Equities
My Current Equities and Potential Positions
| Haleon plc | HLN |
| Classification | Consumer Goods |
| Location | United Kingdom |
| Exchange | New York Stock Exchange |
USD 9.72
Check out Haleon Plc Performance and Haleon Plc Correlation. To learn how to invest in Haleon Stock, please use our How to Invest in Haleon Plc guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Haleon Plc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.